DNA repair and the contribution to chemotherapy resistance

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

doi:10.1186/s13073-025-01488-8

DNA repair and the contribution to chemotherapy resistance

Ksenija Nesic & John J. Krais et al. · 2025-05-26

Links

DOI PubMed

Journal

Genome Medicine

Authors

Ksenija Nesic, Phoebe Parker, Elizabeth M. Swisher, John J. Krais

Funding

Methylation and Mutation Assay to Personalize PARP Inhibitor Therapy Ovarian Cancer Research Alliance Grant ECIG-2025-3-1966 Examining the Role of RNF168 Activity in BRCA1 Mutant Cancers Examining the Role of RNF168 Activity in BRCA1 Mutant Cancers Methylation and Mutation Assay to Personalize PARP Inhibitor Therapy Project 2: Inhibiting AXL to Improve Treatment Response in Endometrial Cancer AACR-AstraZeneca Ovarian Cancer Research Fellowship Funding National Health and Medical Research Council Funding Stafford Fox Medical Research Foundation Funding Alvin J. Siteman Cancer Center through The Foundation for Barnes-Jewish Hospital and the Alvin J. Siteman Cancer Research Fund Funding Cancer Research Foundation Funding Basser Center for BRCA Funding Route 66 Endometrial Cancer SPORE CEP Funding

NCI NIH HHS

R01 CA251817

NCI NIH HHS

K22 CA276631

NIH NCI

1K22CA276631-01

NIH NCI

R01CA251817

NCI NIH HHS

P50 CA265793